AK

Ashok Kumar Dosi

Director Director DIN 09439593
DIN 09439593 First appointment Dec 2021 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Dec 2021
Shareholding value Locked Premium profile

About Ashok Kumar Dosi

Ashok Kumar Dosi has 4 years in corporate governance. Formerly with 1 company, such as C3 Diagnostic And Pathology Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09439593
Primary Designation Director
First Appointment 21 Dec 2021
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Additional Director 21 Dec 2021 2021 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
C3 Diagnostic And Pathology Private Limited
Premium access

Shareholding and investment profile for Ashok Kumar Dosi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashok Kumar Dosi

Ashok Kumar Dosi has 4 years in corporate governance. Formerly with 1 company, such as C3 Diagnostic And Pathology Private Limited. Engaged in General Business. Contributes to corporate operations.

Ashok Kumar Dosi is associated with 0 companies as a director.

Ashok Kumar Dosi has expertise in General Business.

Ashok Kumar Dosi has 4 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available